- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Georgia passes open insurance law, no one cares
A law that took effect in December would allow insurers to sell policies across state lines has no takers. The law was supposed to allow the free market to lower prices and increase choice.
A law that took effect in December last year would allow insurers to sell policies across state lines has no takers. The law was supposed to allow the free market to lower prices and increase choice, but insurers may be waiting for the Supreme Court to decide the constitutionality of the Affordable Care and Patient Protection Act before adjusting their business model.
The Atlanta Journal-Constitution quotes Georgia Insurance Commissioner Ralph Hudgens as being “dumbfounded” by the lack of interest in the law that could allow Georgia consumers to buy health plans that meet the less stringent requirements of other states.
Rep. Matt Ramsey, R-Peachtree City, who sponsored the legislation, blames the apparent lack of interest on the wait-and-see attitude that the Supreme Court case is having on healthcare reform. Insurers may be reluctant to overhaul their business processes before the expected ruling in June.
The law applies to the individual market, not to Georgians who are insured through their employers. If the law plays out as intended, it would allow an insurer to offer any other state plan to Georgia’s private market customers.
The Atlanta Journal-Constitution says four other states have enacted such a laws, but they have not produced any new insurance products either.
Go back to the Managed Healthcare Executive eNews newsletter.
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
